|Bid||137.55 x 800|
|Ask||143.11 x 800|
|Day's Range||138.85 - 140.69|
|52 Week Range||126.01 - 189.00|
|Beta (5Y Monthly)||0.95|
|PE Ratio (TTM)||204.01|
|Earnings Date||Nov 01, 2021 - Nov 05, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||205.47|
Subscribe to Yahoo Finance Plus to view Fair Value for JAZZLearn more
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors’ consensus returns have been exceptional. In the following paragraphs, we find out […]
September's been a rough month for the stock market, and on Monday, the S&P 500 had its worst day in months, falling 1.7%. Instead, it may be time to load up on three growth stocks near their 52-week lows, including Jazz Pharmaceuticals (NASDAQ: JAZZ), Activision Blizzard (NASDAQ: ATVI), and Alibaba Group Holding (NYSE: BABA). Healthcare company Jazz Pharmaceuticals is trading at around $130 and has been falling more than 20% year to date, while the S&P 500 has risen by 16%.